|
|
An analysis on plasma microRNA profiling and function among population exposed to asbestos |
YIN Xian-hong, XIA Hai-ling, JIANG Zhao-qiang, YU Min, WU Wei, ZHANG Min, ZHU Li-jin, CHEN Jun-qiang, XIAO Yun, YING Shi-bo, LOU Jian-lin, ZHANG Xing
|
Institute of occupational diseases prevention and control, Zhejiang Academy of Medical Sciences,Hangzhou, Zhejiang, 310013, China |
|
|
Abstract Objective To investigate the effects of asbestos exposure on plasma miRNA expression. Methods Plasma samples were collected from control group and asbestos-exposed group (time of exposure >10 years) and three samples from each group were selected to detect differentially expressed miRNA using LC Sciences miRNA Microarray-Single. The target genes of differential miRNA were predicted by three kinds of online software, Target Scan,miRanda and PicTar.GO term enrichment and KEGG pathways were analyzed. Results The results of microarray indicated that there were 40 differential miRNA expression between exposed and control groups(P<0.05), and the signal value of 9 differential miRNA exceeded 500. After analyzing signal pathways of target genes of 5 miRNA, of which the signal values were over 500, these target genes were found mainly involved in pathways associated with cancer and metabolism, including potential function targets of FAS, TP53 and FGFR3. Conclusion Asbestos exposure can result in differentially expressed miRNA in the plasma from workers occupationally exposed to asbestos and the target genes of these miRNA may play important roles in the pathways of cancer. However, the mechanism of these miRNA in asbestos-related diseases needs to be further studied in the future.
|
Received: 05 August 2015
Revised: 27 October 2015
Published: 07 December 2017
|
|
|
|
|
[1] 张敏,张幸.石棉和人造矿物纤维诱导细胞凋亡机制的研究进展[J].中华劳动卫生职业病杂志,2009,27(1): 61-63. [2] IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: asbestos[J]. IARC Monogr Eval Carcinog Risk Chem Man,1977,14(2): 1-106. [3] PASETTO R, TERRACINI B, MARSILI D, et al. Occupational burden of asbestos-related cancer in Argentina, Brazil, Colombia, and Mexico[J]. Ann Glob Health,2014,80(4): 263-268. [4] XU Y, ZHENG M, MERRITT R E, et al. miR-1 induces growth arrest and apoptosis in malignant mesothelioma[J]. Chest, 2013,144(5): 1632-1643. [5] KUBO T, TOYOOKA S, TSUKUDA K, et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma[J]. Clin Cancer Res,2011,17(15): 4965-4974. [6] KIRSCHNER M B, CHENG Y Y, BADRIAN B, et al. Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma[J]. J Thorac Oncol,2012,7(7): 1184-1191. [7] KIRSCHNER M B, KAO S C, EDELMAN J J, et al. Haemolysis during sample preparation alters microRNA content of plasma[J]. PLoS One,2011,6(9): e24145. [8] SANTARELLI L, STRAFELLA E, STAFFOLANI S, et al. Association of miR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma[J]. PLoS One,2011,6(4): e18232. [9] HANSON E K, LUBENOW H, BALLANTYNE J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs[J]. Anal Biochem,2009,387(2): 303-314. [10] HAMMOND S M. MicroRNAs as tumor suppressors[J]. Nat Genet, 2007,39(5): 582-583. [11] ACUNZO M, ROMANO G, WERNICKE D, et al. MicroRNA and cancer-a brief overview[J]. Adv Biol Regul,2015(57): 1-9. [12] HASAN M M, AKTER R, ULLAH M S, et al. A computational approach for predicting role of Human microRNAs in mers-CoV genome[J]. Adv Bioinformatics,2014(2014): 967946. [13] XUN M, MA C F, DU Q L, et al. Differential expression of miRNAs in enterovirus 71-infected cells[J]. Virol J,2015,12(1): 56. [14] SALLUSTIO F, SERINO G, COSTANTINO V, et al. MiR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells[J]. PLoS One,2013,8(7): e68296. [15] XU K, LIANG X, CUI D, et al. miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells[J]. Mol Carcinog,2013,52(1): 70-78. [16] NAKAZAWA K, DASHZEVEG N, YOSHIDA K. Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage[J]. FEBS J,2014,281(13): 2937-2944. [17] DRAYTON R M, PETER S, MYERS K, et al. MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer[J]. Oncotarget,2014,5(15): 6375-6386. [18] AMATO K R, WANG S, HASTINGS A K, et al. Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC[J]. J Clin Invest,2014,124(5): 2037-2049. [19] YANG S, JI M, ZHANG L, et al. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration[J]. Cell Signal,2014,26(2): 343-351. [20] SIEBEL A, CUBILLOS-ROJAS M, Santos RC, et al. Contribution of S6K1/MAPK signaling pathways in the response to oxidative stress: activation of RSK and MSK by hydrogen peroxide[J]. PLoS One,2013,8(9): e75523. |
|
|
|